Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
about
Testosterone therapy in the new era of Food and Drug Administration oversightTestosterone deficiency in the aging maleA systematic review of the association between lower urinary tract symptoms and falls, injuries, and fractures in community-dwelling older men.RigiScan data under long-term testosterone therapy: improving long-term blood circulation of penile arteries, penile length and girth, erectile function, and nocturnal penile tumescence and duration.Testosterone Deficiency and Nocturia: A Review.Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study.Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis.Andropause - state of the art 2015 and review of selected aspects.Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer.Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary functionSex differences in the aging pattern of renin-angiotensin system serum peptidases.Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management.Testosterone Replacement Therapy and Mortality in Older Men.Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism.Testosterone Therapy in Men With Prostate Cancer.Aging and sexual health: getting to the problem.Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).Awareness and experience of andropause symptoms in men referring to health centers: a cross-sectional study in Iran.Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes.UK policy statements on testosterone deficiencyTestosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men.The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).Testicular function during puberty and young adulthood in patients with Klinefelter's syndrome with and without spermatozoa in seminal fluid.Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study.Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.Bone mineral density at distal forearm in men over 40 years of age in Mae Chaem district, Chiang Mai Province, Thailand: a pilot study.Are urge incontinence and aging risk factors of erectile dysfunction in patients with male lower urinary tract symptoms?Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015.Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study.Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men."Aging males" symptoms and general health of adult males: a cross-sectional study.Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism.Analysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men.Controversies in the diagnosis and management of testosterone deficiency syndrome.
P2860
Q26747665-C63DB8FB-FA2D-432E-B610-E2D099B3DE68Q26770414-FC2CCBEF-D598-4AA0-867B-EFB7F43F3DF7Q30251608-1C4B4727-539C-4A49-A44F-8F08C20423D5Q31134084-6776E26F-9CD6-43D2-AEBF-E297A045033DQ33642001-A9F037E6-2ED0-43BB-93E6-1BFBDF44A8B5Q34510099-221F899B-FB40-4B1B-A587-8054E03389ADQ34531114-CE7FE5ED-F01B-4F53-829C-0CF233D0B6E7Q35632491-650760A8-456D-4ED3-B6E2-10EC846AC527Q36304676-E494F9BC-24A8-4AC3-A13F-728F19D410A4Q36319340-A50B240E-C5AA-4AA3-B201-A570761570BBQ36752480-24D01D74-3F70-4129-ACF0-9C09BC43EBA1Q37624602-42A5091A-1C58-49FA-AC03-1ED22908A292Q38546659-B08D5625-0190-4FB1-A829-550411D8AA78Q38572877-57023800-F417-43C3-9ED3-783A4C33276FQ38611434-AC35178F-FF62-4A1C-8639-463EF9B5F28EQ38634958-768F5478-2743-4963-886E-FB50B790C9F8Q38683604-5478F32E-5ACE-4545-8D61-B6B983D4C167Q38738470-D4084157-B156-4AD4-B42D-D64CC58BBD8CQ38789981-C7422027-0B53-4CB6-8341-68C34B5BCDA1Q38796233-AACEB7DA-D812-4F5B-A0AF-0B61A2793381Q38873488-D48CBD15-9A56-423F-835F-43F2E0E7CA34Q39185694-4045993B-85F0-413D-A4AC-985733C55DB3Q39187384-35822867-94C6-4A01-B8D9-B2499FE6D29CQ39255893-9884A4F5-1119-4F5A-884A-0B7928F5646CQ39280815-E9E38090-B26D-4468-BB46-F75F650FE5E6Q39280821-615D48CB-2F50-43FE-B002-8B32EE9E7105Q39407433-6E53AFD4-03A6-4F43-80D6-4E23F42E7F76Q39607039-3CCD5BCA-509B-4518-9E49-777061E068BCQ39959100-BF27C306-C0A9-4ABC-930B-443FC9454816Q40112524-5D1987C6-74A2-4EDA-BE55-7F007307FB94Q40211345-1ACED55C-A397-403E-81A0-5B0D57B47FCDQ40341847-CE127D19-9B51-47B8-ABBF-34E19603443CQ40342016-94277DFC-D0C0-4377-86EF-472C6A92F3DDQ40496295-AC1052BD-686C-40ED-9969-BD1B7DEF07B5Q40582717-D2800F44-9972-4FD4-BA56-E9EA247B62FFQ40806115-A24E6946-156D-4A98-8D60-633BF5FD8CCAQ40834816-4D1376DE-BA8C-4112-90ED-E44994F89675Q40883356-287C1EA4-6ECF-4A4D-90E0-4A1FDF968F52Q41352741-F7C349F5-FC32-4435-889B-6E5333E375FCQ42201666-741F3C1A-5609-4B0A-A520-0D4CEA3F0158
P2860
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
@ast
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
@en
type
label
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
@ast
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
@en
prefLabel
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
@ast
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
@en
P2093
P2860
P1433
P1476
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
@en
P2093
Abraham Morgentaler
Bruno Lunenfeld
George Mskhalaya
Michael Zitzmann
Svetlana Kalinchenko
Yuliya Tishova
P2860
P356
10.3109/13685538.2015.1004049
P50
P577
2015-02-06T00:00:00Z